Skip to main content
Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
8.35
-0.07 (-0.77%)
Nov 21, 2024, 12:24 PM EST - Market open

Amneal Pharmaceuticals Revenue

Amneal Pharmaceuticals had revenue of $702.47M in the quarter ending September 30, 2024, with 13.29% growth. This brings the company's revenue in the last twelve months to $2.68B, up 12.32% year-over-year. In the year 2023, Amneal Pharmaceuticals had annual revenue of $2.39B with 8.20% growth.

Revenue (ttm)
$2.68B
Revenue Growth
+12.32%
P/S Ratio
0.92
Revenue / Employee
$341,455
Employees
7,850
Market Cap
2.59B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.39B181.30M8.20%
Dec 31, 20222.21B118.64M5.67%
Dec 31, 20212.09B101.15M5.08%
Dec 31, 20201.99B366.15M22.51%
Dec 31, 20191.63B-36.62M-2.20%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PACS Group 3.56B
Concentra Group Holdings Parent 1.88B
LivaNova 1.24B
ACADIA Pharmaceuticals 929.24M
TransMedics Group 401.09M
Zai Lab 355.75M
Janux Therapeutics 13.05M
Revenue Rankings

AMRX News

More News